LIVE

BAX

Baxter International Inc.

BAX

NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $11.2B

$22.65

▲ +4.43%

View full research view

Our plain-language verdict, the thesis, risk factors, and what is changing about the business.

View research view

52-Week Range

$15.73 - $31.22

P/E

-10.79

Fwd P/E

11.80

Beta

0.64

Div Yield

0.92%

Avg Vol

7.3M

Shares Out

516.3M

Mkt Cap

$11.2B

Price action

Price chart

Down 30.3% over the trailing year

1W
1M
3M
6M
YTD
1Y
5Y
MAX

Total returns

Price performance

Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.

Why we rate it this way

The thesis at a glance

Bull and bear case · plain-English context across the five lenses we evaluate.

▲

Bull Case

4 reasons

  • Global distribution network
  • Comprehensive medical technology portfolio
  • Strong research and development capabilities
  • Established relationships with healthcare providers
▼

Bear Case

1 risk

  • Low volatility (beta 0.6).

Growth

Turning profitable

Aging global population

Value

Undervalued - trading well below Medical Devices peers

Momentum

Hot

+30.0% over 3m

Quality

Stable

Strong fundamentals

Dividend

Modest

0.92% yield

Earnings track record

Latest print - beat on both lines

AI-summarized recap of last quarter, plus the surprise on every print.

Next: Apr 29, 2026

“
Q2 26 RECAP

APR 30, 2026

Reported EPS of $0.36 vs $0.31 consensus (+16.1% surprise). Revenue of $2.7B vs $2.6B expected (+3.3%). Beat on both top and bottom lines.

EPS beat +16.1%
Rev beat +3.3%
Double beat

EPS surprise · last 4Q

1 of 1 beats

Q2 26

+16.1%

Next: Apr 29, 2026

Revenue trend · last 8Q

—

—

-29%

+5%

+4%

+5%

+8%

+3%

Q2 24

Q3 24

Q4 24

Q1 25

Q2 25

Q3 25

Q4 25

Q1 26

$2.7B

$2.7B

$2.8B

$2.6B

$2.8B

$2.8B

$3.0B

$2.7B

Margins · last 8Q

Gross

33.0%

Operating

2.4%

Profit

-0.6%

View full earnings history →

Wall Street consensus

4 analysts · 50% Buy

Live ratings and price targets aggregated across covering analysts.

Buy

2

50%

Hold

1

25%

Sell

1

25%

Median Price Target

$27.00

▲ +19.2% vs $22.65

Low $27.00
Median $27.00
High $27.00

Latest: Citi · May 28, 2026

1 analyst covering

View full analyst page →

vs Industry

How BAX stacks vs Medical - Instruments & Supplies

Stock metrics vs industry averages. Green = better than industry.

Industry comparison data unavailable for this stock.